Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2023 ∙ Zhou, Q. Zeng, F. Meng, Y. Liu, Y. Liu, H. Deng, G.

Serological response following COVID-19 vaccines in patients living with HIV: a dose-response meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Mu, Y. Wu, H. Jiang, Z. Liu, K. Xue, X. Zhang, W. Chen, Z.

Serological Responses after a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Wu, P. C. Huang, I. H. Wang, C. W. Chung, W. H. Chen, C. B.

Severe Cutaneous Adverse Reactions After COVID-19 Vaccination: A Systematic Review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Arabi, M. Al-Najjar, Y. Mhaimeed, N. Salameh, M. A. Paul, P. AlAnni, J. Abdelati, A. A. Laswi, I. Khanjar, B. Al-Ali, D. Elshafeey, A. Mhaimeed, O. Burney, Z. D'Souza, A. Sinha, P. Bhatti, M. Pillai, K. V. Homssi, M. Bshesh, K. Yagan, L. Zakaria, D.

Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: A systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Sulis, G. Kim, J. Y. Rodrigue, V. Gore, G. Peebles, A. Ulrich, A. K. Horn, M. Basta, N. E.

Sex-disaggregated effectiveness data reporting in COVID-19 vaccine research: a systematic review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2023 ∙ Xiao, Hong Vaidya, Riha Liu, Fang Chang, Ximing Xia, Xiaoqian Unger, Joseph M.

Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis

  • Americas
  • United States of America
  • All age groups
  • COVID-19
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Vardavas, C. Nikitara, K. Aslanoglou, K. Lagou, I. Marou, V. Phalkey, R. Leonardi-Bee, J. Fernandez, E. Vivilaki, V. Kamekis, A. Symvoulakis, E. Noori, T. Wuerz, A. Suk, J. E. Deogan, C.

Social determinants of health and vaccine uptake during the first wave of the COVID-19 pandemic: A systematic review

  • All age groups
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Garg, R. K. Paliwal, V. Malhotra, H. S. Singh, B. P. Rizvi, I. Kumar, N.

Spectrum of Serious Neurological and Psychiatric Adverse Events in Indian COVID-19 Vaccine Recipients: A Systematic Review of Case Reports and Case Series

  • South-East Asia
  • India
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Liu, J. Cao, F. Luo, C. Guo, Y. Yan, J.

Stroke Following Coronavirus Disease 2019 Vaccination: Evidence Based on Different Designs of Real-World Studies

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
High
2023 ∙ Jia, Y. Fu, B. Dong, L. Zhao, M.

Sweet syndrome induced by SARS-CoV-2 vaccines: A systematic review of patient-report studies

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...